TABLE 2.
Characteristics of CRKP infectionsa
| Characteristics | All patients (n = 94) | Liver (n = 53) | Kidney (n = 21) | Lung (n = 20) | P valueb |
|---|---|---|---|---|---|
| Infection types | |||||
| Lung infection | 60 (63.8%) | 33 (62.3%) | 9 (42.9%) | 18 (90.0%) | 0.006 |
| Intra-abdominal infection | 9 (9.6%) | 9 (17.0%) | 0 (0) | 0 (0) | 0.014 |
| BSI | 27 (28.7%) | 17 (32.1%) | 7 (33.3%) | 3 (15.0%) | 0.335 |
| Genitourinary tract infection | 5 (5.3%) | 0 (0) | 5 (23.8%) | 0 (0) | 0.001 |
| Skin and soft tissue infection | 2 (2.1%) | 1 (1.9%) | 0 (0) | 1 (5.0%) | 0.430 |
| Hepatobiliary infection | 5 (5.3%) | 5 (9.4%) | 0 (0) | 0 (0) | 0.226 |
| Surgical site infection | 8 (8.5%) | 4 (7.5%) | 3 (14.3%) | 1 (5.0%) | 0.597 |
| No. of infection sites | |||||
| 1 | 79 (84.0%) | 44 (83.0%) | 18 (85.7%) | 17 (85.0%) | 0.962 |
| 2 | 11 (11.7%) | 5 (9.4%) | 3 (14.3%) | 3 (15.0%) | |
| 3 | 2 (2.1%) | 2 (3.8%) | 0 (0) | 0 (0) | |
| 4 | 2 (2.1%) | 2 (3.8%) | 0 (0) | 0 (0) |
The data are n (%). BSI, bloodstream infection; CRKP, carbapenem-resistant K. pneumoniae.
P value comparing liver, kidney, and lung transplant, as well as distributions, where applicable.